Document is current

Article History

Received: 6 January 2023

Accepted: 2 November 2023

First Online: 20 November 2023

Declarations

:

: This study was approved by the institutional review board (IRB) of the National Cancer Institute-Cairo University, Cairo 11796, Egypt, which constituted and operates according to ICH-GCP guidelines. The study approval no. was 2211-504-024. Consent to Participate: no consent was required because the study used the regular hospital admission and follow-up data. Data collection was anonymously done to avoid breaking any privacy or confidentiality rights.

: Not applicable.

: Prof Hatem Aboul Kassem is a co-author of this study and an Associate Editor of the journal. He was not involved in handling this manuscript during the submission and review processes. The rest of the authors have no conflict of interest to declare.